The Tübingen Centre for Academic Drug Discovery (TüCAD2), founded in 2012, is part of the University's excellence strategy. TüCAD2 is closely connected to the Excellence Cluster iFIT, ICEPHA (Interfaculty Center for Pharmacogenomics) and to NCT-SW (Nationales Zentrum für Tumorerkrankungen-SüdWest) and focus on pharmacological validation of genetically identified targets. The strong translational focus has brought four compounds "first into human" so far. An essential part of TüCAD2 is a teaching concept, in which both a med chem curriculum and a MedChemCampus play a major part. Together with the GDCh Division of Medicinal Chemistry, TüCAD2 started the MedChemCampus events in 2023, dealing with case studies, presented by eminent drug discovery experts from both industry and academia.

Topics: Case studies dealing with challenges in drug discovery
e.g. pharmacokinetics, structural biology, lead optimisation, safety, selectivity, brain-penetrance, resistance, macrocycles

Target Audience
- Young professionals in drug discovery & medicinal chemistry (academia and industry)
- PostDocs and graduate students in medicinal chemistry

15/16 September 2025
Tübingen
Website

10/11 October 2023
Tübingen
Flyer